|
134488 |
BRADY NV |
Pack of 1 Piece(s) |
EUR 698.37 |
Description: Description Dutch: Brady LINK360 cloudsoftware - 3 uur bedrijfsspecifieke training; Description French: 3 heures de formation dédiée à la société sur le logiciel cloud Brady LINK360 |
Gel Company Laboratories manufactures the the gelcompany reagents distributed by Genprice. The The Gelcompany reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Gel Company. Other The products are available in stock. Specificity: The Category: Gelcompany
True Blue |
TargetMol Chemicals |
5mg |
Ask for price |
- SMILES: N=C(C1=CC=C(OC(/C=C/C2=CC3=CC(C(N)=N)=CC=C3O2)=C4)C4=C1)N.Cl.Cl
- Formula: C20H18Cl2N4O2
|
Description: True Blue |
JBS True Blue |
MiTeGen |
300 µl |
EUR 16 |
Description: JBS True Blue |
Link360 Cloud Software 3h company specific training AI AIDC |
BRADY NV |
Pack of 1 Piece(s) |
EUR 698.37 |
Description: Description Dutch: Brady LINK360 cloudsoftware - 3 uur bedrijfsspecifieke training; Description French: 3 heures de formation dédiée à la société sur le logiciel cloud Brady LINK360 |
Test Assays information
Ebola Virus Secreted Glycoprotein (sGP) (Bundibugyo) |
EBOVUG2007-SGP-50 |
The Native Antigen Company |
0.05 |
EUR 671.04 |
Description: Recombinant Ebolavirus BDBV(subtype Bundibugyo,strain Uganda 2007) Small/secreted Glycoprotein (sGP) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
Ebola Virus Secreted Glycoprotein (sGP) (Bundibugyo) |
EBOVUG2007-SGP-500 |
The Native Antigen Company |
0.5 |
EUR 4847.85 |
Description: Recombinant Ebolavirus BDBV(subtype Bundibugyo,strain Uganda 2007) Small/secreted Glycoprotein (sGP) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
Diphtheria Toxin |
DIP-TNL-100 |
The Native Antigen Company |
0.1 |
EUR 302.36 |
Description: Purified diphtheria toxin from Corynebacterium diphtheriae. |
Diphtheria Toxin |
DIP-TNL-1000 |
The Native Antigen Company |
1.0 |
EUR 505.2 |
Description: Purified diphtheria toxin from Corynebacterium diphtheriae. |
Dengue Virus Serotype 1 NS1 Protein (HEK293) |
DENV1-NS1-100 |
The Native Antigen Company |
0.1 |
EUR 251.33 |
Description: Recombinant Dengue Virus serotype 1 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
Dengue Virus Serotype 1 NS1 Protein (HEK293) |
DENV1-NS1-500 |
The Native Antigen Company |
0.5 |
EUR 944.06 |
Description: Recombinant Dengue Virus serotype 1 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
Dengue Virus Serotype 1 VLP |
DENV1-VLP-100 |
The Native Antigen Company |
0.1 |
EUR 400.23 |
Description: Recombinant Dengue Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 399-497). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 1 VLP |
DENV1-VLP-500 |
The Native Antigen Company |
0.5 |
EUR 1701 |
Description: Recombinant Dengue Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 399-497). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 2 NS1 Protein (HEK293) |
DENV2-NS1-100 |
The Native Antigen Company |
0.1 |
EUR 251.33 |
Description: Recombinant Dengue Virus serotype 2 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
Dengue Virus Serotype 2 NS1 Protein (HEK293) |
DENV2-NS1-500 |
The Native Antigen Company |
0.5 |
EUR 924.92 |
Description: Recombinant Dengue Virus serotype 2 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
Dengue Virus Serotype 2 VLP |
DENV2-VLP-100 |
The Native Antigen Company |
0.1 |
EUR 400.23 |
Description: Recombinant Dengue Virus serotype 2 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 397-495). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 2 VLP |
DENV2-VLP-500 |
The Native Antigen Company |
0.5 |
EUR 1701 |
Description: Recombinant Dengue Virus serotype 2 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 397-495). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 3 NS1 Protein (HEK293) |
DENV3-NS1-100 |
The Native Antigen Company |
0.1 |
EUR 378.9 |
Description: Recombinant Dengue Virus serotype 3 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
Dengue Virus Serotype 3 NS1 Protein (HEK293) |
DENV3-NS1-500 |
The Native Antigen Company |
0.5 |
EUR 1388.02 |
Description: Recombinant Dengue Virus serotype 3 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
Dengue Virus Serotype 3 VLP |
DENV3-VLP-100 |
The Native Antigen Company |
0.1 |
EUR 400.23 |
Description: Recombinant Dengue Virus serotype 3 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 399-492). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 3 VLP |
DENV3-VLP-500 |
The Native Antigen Company |
0.5 |
EUR 1701 |
Description: Recombinant Dengue Virus serotype 3 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 399-492). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 4 Envelope Protein (HEK293) |
DENV4-ENV-100 |
The Native Antigen Company |
0.1 |
EUR 265.36 |
Description: Recombinant Dengue Virus serotype 4 envelope protein antigen, produced in 293 human cells. The protein consists of amino acids 280-678 (polyprotein positions) with a C-terminal His6-tag, separated from the protein by a Gly6 linker. |